South Korea Expression Vector Market Insight
Published: 22 July 2026 | Report Format: Electronic (PDF) | Author: Komal and Radhika
Through 2035, the South Korean expression vector market is expected to expand at a compound annual growth rate (CAGR) of 8.64%, propelled by the development of biologics and gene therapy.
South Korea Expression Vector Market Insights Forecasts to 2035
- The South Korea Expression Vector Market Size Was Estimated USD 126.8 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.64% from 2025 to 2035
- The South Korea Expression Vector Market Size is Expected to rise around USD 290.5 Million by 2035
Notable Insights for the South Korea Expression Vector Market
- According to vector type segmentation, non-viral vectors are expanding at the fastest rate, while viral vectors (AAV, lentivirus) generated the most revenue in 2024.
- According to application segmentation, adoption is led by gene therapy development, while biopharmaceutical discovery and vaccine development have substantial growth potential.
- Government support claims that South Korea's Ministry of Health and Welfare efforts and biohealth policy programs boost supplier trust in cutting-edge vector production equipment.
- In terms of revenue, Dr. Park CDMO operates a 5,000L per batch AAV production capacity with anticipated cGMP certification, and Samsung Biologics started vector synthesis services in Q1 2026.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
- AI-Driven Biotech & Vector Analytics Insights
Decisions Advisors offers innovative AI-driven research services on vector design optimization, pipeline development of gene therapy and manufacturing efficiency for the South Korea expression vectors market. Growth opportunities in viral and non-viral vector platforms in the gene therapy and vaccines domain are provided by the study.
- Robust Research Methodology with Accurate Forecasting Models
The report involves both primary and secondary research, with the former comprising direct interviews with CDMOs, biopharmaceutical firms, and research organizations, while the latter includes health records and clinical trial information provided by the government and industry reports. The purpose is to ensure accurate market estimation and CAGR forecasting.
- Comprehensive Competitive and Ecosystem Analysis
The report studies key vendors supplying expression vectors, transfection reagents and gene delivery systems. The report offers a detailed insight into the impact of competitive positioning, innovations in vector technology platforms, strategic alliances, regulatory developments, and opportunities that are shaping the South Korea Expression Vector Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea expression vector market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Expression Vector Market
- Samsung Biologics
- Celltrion
- Dr. Park CDMO
- Bio Design Lab
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Takara Bio Inc.
- Bio-Rad Laboratories
- Promega Corporation
- Agilent Technologies
Recent Developments:
- In February 2025, worked with a biotechnology research partner to improve the creation of expression vector-based biologics, speeding up the expression of recombinant proteins and optimizing the biosimilar process.
- In September 2024, to assist preclinical research and early-stage biologics manufacturing projects in South Korea, an integrated plasmid DNA and expression vector production service was introduced.
Market Segmentation:
South Korea Expression Vector Market, By Vector Type
- Viral Vectors
- Non-Viral Vectors
South Korea Expression Vector Market, By Workflow
-
- Upstream Processing
- Downstream Processing
South Korea Expression Vector Market, By Application
-
- Gene Therapy Development
- Cell Therapy Development
- Vaccine Development
- Biopharmaceutical Discovery
- Biomedical Research
Expert Views:
The market for vector expression in South Korea is really going to take off in the future. This is because of all the things being discovered in biologics production and gene therapy. The government is also putting a lot of money into biotechnology platforms. All of this will make the market for vector expression in South Korea very competitive. People are getting more interested in therapies and that means the market for vector expression will just keep growing until 2035.
Author: Komal and Radhika By Decisions Advisors and Consulting